Cerebral Vasculopathy in Children with Neurofibromatosis Type 1
Cancers · 23.10.2023 · 15 (20) · 5111
DOI: 10.3390/cancers15205111 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 23.10.2023. Verfasst von Laura L Lehman und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Boston Children's Hospital and Harvard Medical School, Boston, MA 02115, USA. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NICHD NIH HHS.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Cerebrovascular abnormalities are a severe and often underrecognized complication of childhood neurofibromatosis type 1 (NF1). There are no prospective studies of cerebral vasculopathy in NF1; thus, the estimated frequency of vasculopathy varies between studies. The data is difficult to interpret due to the retrospective data collection and variability in whether imaging is done based on screening/surveillance or due to acute neurologic symptoms. The prevalent NF1-associated cerebral vasculopathy is moyamoya syndrome (MMS). Vascular changes can present without symptoms or with acute TIA or stroke-like symptoms or a range of progressive neurologic deficits. Advanced imaging may enhance sensitivity of neuroimaging in children. Medical and/or surgical interventions may prevent short- and long-term complications. Challenges for establishment of a screening protocol for cerebral vasculopathy in children with NF1 include the relatively large number of patients with NF1, the potential need for sedation to achieve quality imaging and the broad age range at time of detection for cerebral vascular changes. The goal of this review is to present the epidemiology, clinical presentation, imaging features and medical/surgical management of cerebral arteriopathies in children with NF1.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, Boston Children's Hospital and Harvard Medical School, Boston, MA 02115, USA.
Förderung
- NICHD NIH HHS
Zitieren
APA
Lehman, L. L., & Ullrich, N. J. (2023). Cerebral Vasculopathy in Children with Neurofibromatosis Type 1. Cancers, 15(20), 5111. https://doi.org/10.3390/cancers15205111
Vancouver
Lehman LL, Ullrich NJ. Cerebral Vasculopathy in Children with Neurofibromatosis Type 1. Cancers. 2023;15(20):5111. doi:10.3390/cancers15205111
BibTeX
@article{Lehman2023,
author = {Lehman, Laura L and Ullrich, Nicole J},
title = {Cerebral Vasculopathy in Children with Neurofibromatosis Type 1},
journal = {Cancers},
year = {2023},
volume = {15},
number = {20},
pages = {5111},
doi = {10.3390/cancers15205111}
}
EUVIMED